Literature DB >> 35186159

A Negative Correlation Between Blood Glucose Level and 68 Ga-DOTA-TOC Uptake in the Pancreas Uncinate Process.

Dongkyu Oh1, Hongyoon Choi1, Jin Chul Paeng1, Keon Wook Kang1, Gi Jeong Cheon1.   

Abstract

PURPOSE: 68 Ga-DOTA-TOC uptake in the pancreas uncinate process is often found due to physiologic expression of somatostatin receptors (SSTR). We investigated the association of physiologic 68 Ga-DOTA-TOC uptake in the pancreas uncinate process with blood glucose level.
METHODS: 68 Ga-DOTA-TOC PET scans acquired from 44 patients (male:female = 20:24, age = 50.8 ± 14.8y [mean ± SD]) were retrospectively analyzed. The blood glucose level (BGL) was examined before 68 Ga-DOTA-TOC injection. Patients diagnosed with diabetes mellitus and patients with BGL over 200 mg/dl were excluded. 68 Ga-DOTA-TOC uptake was measured by the maximum standardized uptake values (SUVmax). Additionally, SSTR-positive volume (SV) in the pancreas uncinate process was measured with two different thresholds: by SUV cutoff of 2.5 (SV2.5) and 40% of SUVmax (SV40%). These measurements on 68 Ga-DOTA-TOC PET were correlated with BGL.
RESULTS: The mean of SUVmax of the pancreas uncinate process was 6.51 ± 2.04. SV2.5 was 17.81 ± 7.14 cm3, and SV40% was 18.20 ± 8.83 cm3. A significant negative correlation was found between SUVmax of the pancreas uncinate process and BGL (r = -0.37, p = 0.01). The ratio between SUVmax of the pancreas uncinate process and SUVmean of the pancreas body also showed a significance negative correlation with BGL (r = -0.40, p = 0.01). SV2.5 (r = 0.27, p = 0.07) and SV40% (r = -0.151, p = 0.32) were not significantly correlated with BGL.
CONCLUSION: Physiologic 68 Ga-DOTA-TOC uptake in the pancreas uncinate process was negatively correlated with BGL. Our results suggested that glycemia could affect physiologic uptake of 68 Ga-DOTA-TOC. © Korean Society of Nuclear Medicine 2021.

Entities:  

Keywords:  68 Ga-DOTA-TOC; Blood glucose level; PET; Pancreatic polypeptide cell; Uncinate

Year:  2021        PMID: 35186159      PMCID: PMC8828813          DOI: 10.1007/s13139-021-00723-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  12 in total

1.  Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas.

Authors:  G M Portela-Gomes; M Stridsberg; L Grimelius; K Oberg; E T Janson
Journal:  Appl Immunohistochem Mol Morphol       Date:  2000-06

Review 2.  Molecular mechanisms of somatostatin receptor trafficking.

Authors:  Zsolt Csaba; Stéphane Peineau; Pascal Dournaud
Journal:  J Mol Endocrinol       Date:  2012-01-25       Impact factor: 5.098

3.  Normal uptake of 68Ga-DOTA-TOC by the pancreas uncinate process mimicking malignancy at somatostatin receptor PET.

Authors:  Hans Jacobsson; Patricia Larsson; Cathrine Jonsson; Emma Jussing; Per Grybäck
Journal:  Clin Nucl Med       Date:  2012-04       Impact factor: 7.794

4.  Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOC.

Authors:  Hanwen Zhang; Maxim A Moroz; Inna Serganova; Thomas Ku; Ruimin Huang; Jelena Vider; Helmut R Maecke; Steven M Larson; Ronald Blasberg; Peter M Smith-Jones
Journal:  J Nucl Med       Date:  2010-12-13       Impact factor: 10.057

5.  Pancreatic polypeptide inhibits somatostatin secretion.

Authors:  Wook Kim; Jennifer L Fiori; Yu-Kyong Shin; Eitan Okun; Jung Seok Kim; Peter R Rapp; Josephine M Egan
Journal:  FEBS Lett       Date:  2014-07-11       Impact factor: 4.124

6.  Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats.

Authors:  Eva Ludvigsen; Richard Olsson; Mats Stridsberg; Eva T Janson; Stellan Sandler
Journal:  J Histochem Cytochem       Date:  2004-03       Impact factor: 2.479

7.  Stimulation of human pancreatic polypeptide secretion by hypoglycemia is independent of adrenergic mechanisms.

Authors:  R Rizza; V Go; P Cryer; C Verdonk; J Gerich
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

Review 8.  Variants and Pitfalls of PET/CT in Neuroendocrine Tumors.

Authors:  Alessio Imperiale; Leah Meuter; Karel Pacak; David Taïeb
Journal:  Semin Nucl Med       Date:  2021-04-07       Impact factor: 4.446

9.  Quantitative analysis of pancreatic polypeptide cell distribution in the human pancreas.

Authors:  Xiaojun Wang; Mark C Zielinski; Ryosuke Misawa; Patrick Wen; Tian-Yuan Wang; Cheng-Zhang Wang; Piotr Witkowski; Manami Hara
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 10.  [68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging.

Authors:  Ute Hennrich; Martina Benešová
Journal:  Pharmaceuticals (Basel)       Date:  2020-03-03
View more
  1 in total

1.  [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?

Authors:  Elena Tabacchi; Emilia Fortunati; Giulia Argalia; Lucia Zanoni; Diletta Calabrò; Silvi Telo; Davide Campana; Giuseppe Lamberti; Claudio Ricci; Riccardo Casadei; Stefano Fanti; Valentina Ambrosini
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.